# Screening for NAFLD-related Advanced Fibrosis in High Risk Population in Diabetology.

> **NCT04435054** · NA · COMPLETED · sponsor: **Hospices Civils de Lyon** · enrollment: 1000 (actual)

## Conditions studied

- Non-Alcoholic Fatty Liver Disease

## Interventions

- **DIAGNOSTIC_TEST:** Non-invasive blood-based and imaging-based tests for the screening of NAFLD-related advanced fibrosis.

## Key facts

- **NCT ID:** NCT04435054
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-28
- **Primary completion:** 2023-10-28
- **Final completion:** 2024-09-11
- **Target enrollment:** 1000 (ACTUAL)
- **Last updated:** 2025-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04435054

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04435054, "Screening for NAFLD-related Advanced Fibrosis in High Risk Population in Diabetology.". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04435054. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
